Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer
PHASE1This is a Phase I study of the ALK/FAK/Pyk2 inhibitor CT-707 in patients wi...
Location
Cancer Hospital of Chinese Academy of Medical Sciences
Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation
PHASE1This Phase Ib/II, open-label, single-arm study evaluates the safety, tolera...
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
PHASE1This study will assess the safety, tolerability, pharmacokinetics and antin...
Location
Fudan University Shanghai Cancer Center